logo
Sign In
Farxiga vs. GlyxambiBerinert vs. CinryzeEmgality vs. QuliptaFarxiga vs. InvokanaFirazyr vs. SajazirGlyxambi vs. InvokanaInvokamet vs. SynjardyOpzelura vs. DupixentOrencia vs. RinvoqQulipta vs. VyeptiStelara vs. TremfyaSynjardy vs. VictozaTaltz vs. BimzelxVyepti vs. Nurtec ODTView all Comparisons
ADHD drugsAnxiety drugsAsthma drugsAtopic dermatitis drugsDepression drugsHeart failure drugsHypertension drugsLymphoma drugsOsteoarthritis drugsRheumatoid arthritis drugsRosacea drugsSchizophrenia drugsType 2 Diabetes drugsView all Indications
Bayer drugsAbbVie drugsAstraZeneca drugsEli Lilly and Company drugsGenetech drugsGlaxoSmithKline (GSK) drugsNovartis drugsPfizer drugsTakeda Pharmaceuticals drugsTeva Pharmaceuticals drugsAmgen drugsView all Manufacturers
Beta-Adrenergic BlockerAngiotensin Converting Enzyme InhibitorAngiotensin 2 Receptor BlockerCalcium Channel BlockerDiureticsHMG-CoA Reductase InhibitorProton Pump InhibitorSelective Serotonin Reuptake InhibitorNorepinephrine Reuptake InhibitorBenzodiazepinesOpioid AgonistsNonsteroidal Anti-inflammatory DrugsAntiepileptic AgentsAntipsychoticsAntihistaminesView all Classes
Wegovy®Ozempic®Mounjaro®Zepbound®Jardiance®Farxiga®Dupixent®Trulicity®Lyrica®Lipitor®Effexor®Concerta®Depakote®Trintellix®Rexulti®Rinvoq®Verzenio®Taltz®
For ProvidersRequest DemoJoin Research Panel
For BusinessHCP ChannelCommercial O/SEngageMarketplaceOneHubInsight
Tools & MorePrescribing InfoCoverageSavingsPatient ResourcesA-Z IndicationsCompare Drugs
CompanyAboutInsightsCareersContactSecurity
Legit Script Certified
Get the latest insights in your inbox
Follow us
Legit Script Certified
  • Terms and Conditions
  • Privacy Policy
  • © 2025 PrescriberPoint. All Rights Reserved.

    • Medications for Opioidrelated Disorders

    FiltersReset Filters
    12 results

    • buprenorphine and naloxone

      (Buprenorphine and Naloxone)
      Dr. Reddy's Laboratories Inc.
      Usage: Buprenorphine and naloxone sublingual film is indicated for the treatment of opioid dependence and should be used alongside a comprehensive treatment plan that includes counseling and psychosocial support.

    • buprenorphine and naloxone

      (buprenorphine hydrochloride and naloxone hydrochloride)
      PAI Holdings, LLC dba Pharmaceutical Associates, Inc. and dba PAI Pharma
      Usage: Buprenorphine and naloxone sublingual tablets are indicated for the maintenance treatment of opioid dependence and should be used alongside a comprehensive treatment plan that includes counseling and psychosocial support.

    • lofexidine hydrochloride

      (lofexidine hydrochloride)
      Prasco Laboratories
      Usage: Lofexidine is indicated for reducing opioid withdrawal symptoms to assist adults in the abrupt discontinuation of opioids.

    • lofexidine hydrochloride

      (lofexidine hydrochloride)
      Novadoz Pharmaceuticals LLC
      Usage: Lofexidine tablets are indicated for mitigating opioid withdrawal symptoms to assist adults in the abrupt discontinuation of opioid use.

    • methadone hydrochloride

      (Methadone Hydrochloride)
      VistaPharm, LLC
      Usage: Methadone hydrochloride oral concentrate is indicated for the detoxification and maintenance treatment of opioid addiction, such as heroin or other morphine-like drugs, alongside appropriate social and medical services. Usage is regulated under specific distribution conditions per federal guidelines.

    • methadone hydrochloride

      (Methadone Hydrochloride)
      Aurolife Pharma, LLC
      Usage: Methadone Hydrochloride Tablets are indicated for managing severe, persistent pain requiring long-term opioid treatment when other options are inadequate, and for detoxification and maintenance treatment of opioid addiction. They are not meant for as-needed use and have specific distribution requirements for addiction treatment.

    • nalmefene hydrochloride

      (nalmefene hydrochloride injection)
      Chengdu Shuode Pharmaceutical Co., Ltd
      Usage: Nalmefene Hydrochloride Injection is indicated for the complete or partial reversal of opioid effects, including respiratory depression, and for the management of known or suspected opioid overdose.

    • naloxone hydrochloride

      (NALOXONE HYDROCHLORIDE)
      Hospira, Inc.
      Usage: Naloxone Hydrochloride Injection is indicated for reversing opioid-induced respiratory depression and diagnosing suspected acute opioid overdose. It may also be used adjunctively to help increase blood pressure in septic shock management.

    • naloxone hydrochloride

      (Naloxone Hydrochloride)
      Mylan Institutional LLC
      Usage: Naloxone hydrochloride injection is indicated for the complete or partial reversal of opioid depression, including respiratory depression from natural and synthetic opioids. It is also used to diagnose suspected opioid overdose and may assist in increasing blood pressure during septic shock management.

    • naloxone hydrochloride

      (Naloxone Hydrochloride)
      Endo USA, Inc.
      Usage: Naloxone hydrochloride injection is indicated for reversing opioid depression, including respiratory issues from natural and synthetic opioids, and for diagnosing acute opioid overdose. It may also be used adjunctively to enhance blood pressure in septic shock management.